Case report: clinical improvements observed in first off-label metreleptin treatment of a patient with atypical anorexia nervosa-Reference-Cited by-同舟云学术

Case report: clinical improvements observed in first off-label metreleptin treatment of a patient with atypical anorexia nervosa

Published:2023-10-24 Issue: Volume: Page:
ISSN:1018-8827
Container-title:European Child & Adolescent Psychiatry
language:en
Short-container-title:Eur Child Adolesc Psychiatry

Author:

Hebebrand Johannes^ORCID,Antel Jochen^ORCID,Peters Triinu^ORCID

Abstract

AbstractOff-label metreleptin treatment resulted in cognitive, emotional and behavioral improvements of patients with anorexia nervosa, who presented with hypoleptinemia. We now report a case study of a 16-year-old female patient with atypical anorexia nervosa who was treated off-label with metreleptin for 11 days. She had lost 21 kg over 6 months. Her body mass index at referral for inpatient treatment was 20 kg/m2, her serum leptin level was just within the normal range (2.4 ng/ml). Dosing resulted in prominent improvements of mood and weight phobia entailing a comparatively brief inpatient treatment. The observed improvements are similar to those observed in patients with AN, suggesting overlapping mechanisms with respect to clinical effects induced by elevations of absolute or relative hypoleptinemia. Randomized controlled trials are warranted for both eating disorders.

Funder

Universitätsklinikum Essen

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Developmental and Educational Psychology,General Medicine,Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00787-023-02315-4.pdf

Reference27 articles.

1. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS (1996) Role of leptin in the neuroendocrine response to fasting. Nature 382:250–252

2. American Psychiatric Association (2013) DSM-5; Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC

3. Antel J, Tan S, Grabler M, Ludwig C, Lohkemper D, Brandenburg T, Barth N, Hinney A, Libuda L, Remy M, Milos G, Hebebrand J (2021) Rapid amelioration of anorexia nervosa in a male adolescent during metreleptin treatment including recovery from hypogonadotropic hypogonadism. Eur Child Adolesc Psychiatry 10:1573–1579

4. Ballauff A, Ziegler A, Emons G, Sturm G, Blum WF, Remschmidt H, Hebebrand J (1999) Serum leptin and gonadotropin levels in patients with anorexia nervosa during weight gain. Mol Psychiatry 4:71–75

5. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, Kiess W, Rascher W (1997) Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 82:2904–2910